Clinical Trial Update: Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating sipuleucel-T with or without continuing new hormonal agents in metastatic prostate cancer, and recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• sipuleucel-T (sipuleucel-T)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Prostate Cancer, Metastatic Prostate Cancer | Phase 2 | Status: RECRUITING